Have your own idea? Try our Stock Screener
Tunisian (TUNINDEX) Healthcare Sector Analysis
UpdatedJul 05, 2026
DataAggregated Company Financials
Companies2
- 7D2.4%
- 3M19.3%
- 1Y23.5%
- YTD8.7%
Over the last 7 days, the Healthcare industry has risen 1.5%, driven by gains from every company within the industry. This takes the industry's 12 month performance to a gain of 22%. Earnings are forecast to be flat in the coming years.
Sector Valuation and Performance
Has the Tunisian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 05 Jul 2026 | د.ت334.6m | د.ت148.9m | د.ت18.6m | 17.6x | 18x | 2.2x |
| Tue, 02 Jun 2026 | د.ت305.3m | د.ت149.0m | د.ت18.6m | 16x | 16.4x | 2x |
| Thu, 30 Apr 2026 | د.ت293.6m | د.ت153.8m | د.ت22.2m | 12.9x | 13.2x | 1.9x |
| Sat, 28 Mar 2026 | د.ت282.2m | د.ت153.8m | د.ت22.2m | 12.4x | 12.7x | 1.8x |
| Mon, 23 Feb 2026 | د.ت300.9m | د.ت153.8m | د.ت22.2m | 13.3x | 13.5x | 2x |
| Wed, 21 Jan 2026 | د.ت328.8m | د.ت153.8m | د.ت22.2m | 14.5x | 14.8x | 2.1x |
| Fri, 19 Dec 2025 | د.ت295.5m | د.ت153.8m | د.ت22.2m | 12.9x | 13.3x | 1.9x |
| Sun, 16 Nov 2025 | د.ت262.9m | د.ت153.8m | د.ت22.2m | 11.5x | 11.8x | 1.7x |
| Tue, 14 Oct 2025 | د.ت272.8m | د.ت153.8m | د.ت22.2m | 11.9x | 12.3x | 1.8x |
| Thu, 11 Sep 2025 | د.ت281.6m | د.ت153.7m | د.ت22.2m | 12.2x | 12.7x | 1.8x |
| Sat, 09 Aug 2025 | د.ت305.2m | د.ت147.7m | د.ت19.4m | 15.5x | 15.8x | 2.1x |
| Mon, 07 Jul 2025 | د.ت270.8m | د.ت141.0m | د.ت6.4m | 41x | 42.1x | 1.9x |
| Wed, 04 Jun 2025 | د.ت252.8m | د.ت141.1m | د.ت6.4m | 37.8x | 39.3x | 1.8x |
| Fri, 02 May 2025 | د.ت244.5m | د.ت141.1m | د.ت6.4m | 36.2x | 38x | 1.7x |
| Sun, 30 Mar 2025 | د.ت251.4m | د.ت141.1m | د.ت6.4m | 37.6x | 39.1x | 1.8x |
| Tue, 25 Feb 2025 | د.ت228.7m | د.ت141.1m | د.ت6.4m | 34.5x | 35.5x | 1.6x |
| Thu, 23 Jan 2025 | د.ت231.7m | د.ت141.1m | د.ت6.4m | 35.7x | 36x | 1.6x |
| Sat, 21 Dec 2024 | د.ت233.5m | د.ت141.1m | د.ت6.4m | 35.1x | 36.3x | 1.7x |
| Mon, 18 Nov 2024 | د.ت240.0m | د.ت141.1m | د.ت6.4m | 35.8x | 37.3x | 1.7x |
| Wed, 16 Oct 2024 | د.ت243.6m | د.ت141.1m | د.ت6.4m | 36.3x | 37.9x | 1.7x |
| Fri, 13 Sep 2024 | د.ت237.7m | د.ت136.0m | د.ت5.5m | 40.9x | 42.9x | 1.7x |
| Sun, 11 Aug 2024 | د.ت234.4m | د.ت136.0m | د.ت5.5m | 40.8x | 42.3x | 1.7x |
| Tue, 09 Jul 2024 | د.ت224.9m | د.ت136.0m | د.ت5.5m | 39.2x | 40.6x | 1.7x |
| Thu, 06 Jun 2024 | د.ت220.1m | د.ت115.1m | د.ت13.1m | 16.2x | 16.8x | 1.9x |
| Sat, 04 May 2024 | د.ت236.8m | د.ت115.1m | د.ت13.1m | 17.5x | 18.1x | 2.1x |
| Mon, 01 Apr 2024 | د.ت238.1m | د.ت115.1m | د.ت13.1m | 17.6x | 18.2x | 2.1x |
| Wed, 28 Feb 2024 | د.ت231.7m | د.ت115.1m | د.ت13.1m | 17.1x | 17.7x | 2x |
| Fri, 26 Jan 2024 | د.ت365.3m | د.ت223.6m | د.ت13.6m | 136.6x | 26.8x | 1.6x |
| Sun, 24 Dec 2023 | د.ت370.3m | د.ت223.6m | د.ت13.6m | 136.7x | 27.2x | 1.7x |
| Tue, 21 Nov 2023 | د.ت371.9m | د.ت223.6m | د.ت13.6m | 136.6x | 27.3x | 1.7x |
| Thu, 19 Oct 2023 | د.ت393.7m | د.ت223.6m | د.ت13.6m | 137.5x | 28.9x | 1.8x |
| Sat, 16 Sep 2023 | د.ت393.7m | د.ت204.8m | د.ت8.3m | 144.1x | 47.3x | 1.9x |
| Mon, 14 Aug 2023 | د.ت386.6m | د.ت204.8m | د.ت8.3m | 143.7x | 46.4x | 1.9x |
| Wed, 12 Jul 2023 | د.ت394.0m | د.ت204.8m | د.ت8.3m | 144.3x | 47.3x | 1.9x |
Price to Earnings Ratio
47.3x
Current Industry PE
- There are only 2 companies in the Tunisian Healthcare industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 31% per year over the last three years.
- Meanwhile revenues for these companies have declined 10% per year.
- This means that less sales are being generated overall, but since cost of doing business is lower, profits have been increasing.
Industry Trends
Which industries have driven the changes within the Tunisian Healthcare sector?
| TN Market | 0.24% | |
| Healthcare | 2.39% | |
| Pharma | 2.39% | |
Industry PE
- Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 27.6x.
- Analysts are expecting annual earnings decline of 0.003%, which is less than its past year's earnings decline of 4.0%.
- Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 27.6x.
Forecasted Growth
- Despite it being negative, analysts are least pessimistic on the Pharma industry since they expect its earnings to decline by only 0.003% per year over the next 5 years, which isn't as bad as the other industries.
- In contrast, the Pharma industry is expected to see its earnings growth to stay flat over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| UMED Unité de Fabrication des Médicaments | د.ت10.23 | 2.5% +د.ت8.0m | 24.0% | PE17.6x |